Endovascular Recanalization and Standard Medical Management for Symptomatic Non-acute Intracranial Artery Occlusion:

Huijun Zhang1, Jianjia Han2, Xuan Sun2

  • 1Department of Neurology, Tong Ren Hospital Shanghai Jiaotong University School of Medicine, Shanghai, China.

Frontiers in Neurology
|October 15, 2021
PubMed

Insights

This study evaluates endovascular recanalization (ER) plus standard medical therapy (SMT) for symptomatic non-acute intracranial artery occlusion (sNA-ICAO). The research assesses ER

Area of Science:

  • Neurology
  • Interventional Cardiology
  • Vascular Surgery

Background:

  • Symptomatic non-acute intracranial artery occlusion (sNA-ICAO) presents significant clinical challenges.
  • Patients with sNA-ICAO face high morbidity and recurrent ischemic events despite standard medical therapy (SMT).
  • Existing evidence on endovascular recanalization (ER) for sNA-ICAO is limited to small-sample studies, lacking multicenter, prospective data.

Purpose of the Study:

  • To evaluate the technical feasibility and safety of endovascular recanalization (ER) for patients with symptomatic non-acute intracranial artery occlusion (sNA-ICAO).

Main Methods:

  • A prospective, non-randomized, multicenter cohort registry study involving 15 centers in China (January 2020 - December 2022).
  • Enrollment of consecutive patients with sNA-ICAO, comparing outcomes between those receiving SMT alone and those receiving ER plus SMT.
  • Follow-up for 2 years to assess primary outcomes (stroke incidence) and secondary outcomes (mortality, mRS, NIHSS, cognitive function).

Main Results:

  • Data collection ongoing; primary outcome is stroke incidence at 2 years.
  • Secondary outcomes include all-cause mortality, modified Rankin Scale (mRS), National Institutes of Health Stroke Scale (NIHSS), and cognitive function at various time points.
  • Statistical analysis will involve descriptive statistics and regression models to determine clinical relevance (RRR, ARR, NNT).

Conclusions:

  • The study protocol is designed to address the clinical challenges in managing sNA-ICAO.
  • It aims to provide robust evidence on the safety and feasibility of ER as a treatment option.
  • Findings will inform clinical practice and future research for sNA-ICAO patients.